WallStreetZenWallStreetZen

NASDAQ: INVA
Innoviva Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their INVA stock forecasts and price targets.

Forecast return on equity

Is INVA forecast to generate an efficient return?
Company
4.7%
Industry
-6.54%
Market
40.63%
INVA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is INVA forecast to generate an efficient return on assets?
Company
2.55%
Industry
0.81%
INVA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

INVA earnings per share forecast

What is INVA's earnings per share in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$0.50-77.78%

INVA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
INVA$19.07N/AN/A
IMTX$11.73$16.00+36.40%Strong Buy
ARQT$10.36$17.00+64.09%Strong Buy
GYRE$12.50N/AN/A
TNGX$10.89$14.40+32.23%Strong Buy

Innoviva Stock Forecast FAQ

What is INVA's earnings growth forecast for 2024-2024?

(NASDAQ: INVA) Innoviva's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Innoviva's earnings in 2024 is $145,424,000.

In 2024, INVA is forecast to generate $31,281,248 in earnings, with the lowest earnings forecast at $31,281,248 and the highest earnings forecast at $31,281,248.

If you're new to stock investing, here's how to buy Innoviva stock.

What is INVA's forecast return on equity (ROE) for 2024-2024?

(NASDAQ: INVA) forecast ROE is 4.7%, which is considered weak.

What is INVA's Earnings Per Share (EPS) forecast for 2024-2024?

(NASDAQ: INVA) Innoviva's current Earnings Per Share (EPS) is $2.25. In 2024, INVA's EPS is forecast to hit $0.50 (min: $0.50, max: $0.50).

What is INVA's forecast return on assets (ROA) for 2024-2024?

(NASDAQ: INVA) forecast ROA is 2.55%, which is higher than the forecast US Biotechnology industry average of 0.81%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.